lobbying_activities: 3332481

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3332481	9f6917d2-62f0-4294-b603-0389fd48f242	Q1	HOLLAND & KNIGHT LLP	18466	PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION	2025	first_quarter	MED	Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2026 House and Senate appropriations for the Food and Drug Administration; skin cancer prevention for outdoor workers; use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); nomination of new HHS and FDA leadership.	HOUSE OF REPRESENTATIVES,SENATE	70000		0	0	2025-04-13T07:08:47-04:00